SARS-CoV-2 vaccine safety in adolescents with inflammatory rheumatic and musculoskeletal diseases and adults with juvenile idiopathic arthritis: data from the EULAR COVAX physician-reported registry.

Saskia Lawson-Tovey Pedro M Machado Anja StrangfeldElsa MateusLaure Gossec Loreto CarmonaBernd RaffeinerInita BulinaDaniel ClementeJulija ZepaAna M RodriguesXavier MarietteKimme L Hyrichnull null

Published in: RMD open (2022)

This is an important contribution to research on SARS-CoV-2 vaccine safety in adolescents with RMDs and adults with JIA. It is important to note the low frequency of disease flares, serious AEs and SARS-CoV-2 reinfection seen in both populations, although the dataset is limited by its size.

Keyphrases

sars cov
juvenile idiopathic arthritis
young adults
respiratory syndrome coronavirus
physical activity
disease activity
emergency department
rheumatoid arthritis
primary care
electronic health record
deep learning
data analysis